# Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis

> **NCT02843438** · NA · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 72 (actual)

## Conditions studied

- Subjects Clinically Suspected an Active Source of Toxoplasmosis Chorioretinitis Infection

## Interventions

- **OTHER:** Fluorescein angiography
- **OTHER:** Dilated fundus examination
- **BIOLOGICAL:** Toxoplasmosis serology
- **DRUG:** Anti-toxoplasmosis treatment
- **DRUG:** Anti-inflammatory treatments
- **OTHER:** Puncture in anterior chamber

## Key facts

- **NCT ID:** NCT02843438
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2016-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02843438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02843438, "Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT02843438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*